Skip to main content

Table 2 Comparison between the tumor recurrence group and group with no tumor recurrence regarding pre- and post-radiofrequency TGFB1, AFP, and AFP-L3%

From: α-Fetoprotein (AFP)-L3% and transforming growth factor B1 (TGFB1) in prognosis of hepatocellular carcinoma after radiofrequency

 Tumor recurrencet test
YesNo
Mean ± SDMean ± SDtp value
Pre-TGFB1(ng/mL)62.70 ± 24.7563.33 ± 23.76− 0.0640.950
Post-TGFB1(ng/mL)66.72 ± 16.0854.37 ± 25.421.2270.228
p value0.461< 0.001  
Pre-AFP (ng/mL)91.97 ± 63.0783.92 ± 62.210.3100.758
Post-AFP (ng/mL)66.91 ± 36.3742.89 ± 30.161.8490.072
p value0.093< 0.001  
Pre-AFP-L3%35.53 ± 15.6827.07 ± 12.291.5770.123
Post-AFP-L3%53.10 ± 15.031.56 ± 2.5319.322< 0.001
p value0.036< 0.001